Author

M. Ge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Cell Biology· 1 Ecology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:cell type annotation· 4 Organism:human· 4 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2

Frequent Co-Authors

A. Ahmad· 1 shared A. Fornoni· 1 shared A. Korrensalo· 1 shared A. Lohila· 1 shared A. Mitrofanova· 1 shared A. Putkinen· 1 shared A. Wu· 1 shared B. Shin· 1 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 7 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Ahmad

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

CH4 transport in wetland plants under controlled environmental conditions: untangling the impacts of phenology

M. Ge, A. Korrensalo, A. Putkinen, R. Laiho, L. Kohl, M. Pihlatie, A. Lohila, P. Makiranta, H. Siljanen, E.-S. Tuittila, M. Koskinen

This study measures CH4 fluxes in wetland plants under controlled conditions to assess how phenology and microbial activity influence methane transport.

bioRxiv · Oct 8, 2023 · PreprintEcology

Multi-omics and Pharmacological Characterization of Patient-derived Glioma Cell Lines

M. Wu, R. Yuan, N. Ji, T. Lu, T. Wang, J. Zhang, M. Li, P. Cao, J. Zhao, G. Li, J. Li, Y. Li, Y. Tang, Z. Gao, X. Wang, , J. Chen

This study characterizes 52 patient-derived glioma cell lines with whole-genome sequencing, RNA-seq, and drug response screening, identifying three subtypes and their drug sensitivities and tumorigenic potential.

bioRxiv · Feb 20, 2023 · PreprintCancer Biology

Comprehensive characterization of tumor microenvironment in colorectal cancer via histopathology-molecular analysis

X. Wu, H. Yan, M. Qiu, X. Qu, J. Wang, S. Xu, Y. Zheng, M. Ge, L. Yan, L. Liang

This study characterizes the tumor microenvironment in colorectal cancer using multi-omics and spatial analysis, identifying four subtypes with distinct features and therapeutic responses.

bioRxiv · Feb 16, 2023Cancer Biology

Distinct super-enhancer elements differentially control Il2ra gene expression in a cell-type specific fashion

R. Spolski, P. Li, V. Chandra, B. Shin, C. Liu, J. Oh, M. Ren, Y. Enomoto, E. E. West, S. Christensen, E. C. K. Wan, M. Ge, J.-X. Lin, P. Vijayanand, E. V. Rothenberg, W. J. Leonard

The paper identifies distinct super-enhancer elements that differentially regulate Il2ra expression in DN2/DN3 thymocytes and Treg cells versus mature T and NK cells.

bioRxiv · Nov 18, 2022 · PreprintImmunology

Empagliflozin reduces renal lipotoxicity in experimental Alport syndrome

M. Ge, J. Molina, J. J. Kim, S. K. Mallela, A. Ahmad, J. Varona Santos, H. Al-Ali, A. Mitrofanova, K. Sharma, F. Fontanesi, S. Merscher, A. Fornoni

This study shows empagliflozin reduces renal lipotoxicity and improves kidney function in experimental Alport syndrome by shifting energy substrates from glucose to fatty acids in podocytes.

bioRxiv · Oct 4, 2022Cell Biology

A T-cell independent universal cellular therapy strategy through antigen depletion

D. Li, W. Wang, S. Xie, M. Ge, R. Wang, Q. Xu, Y. Sun, J. Zhu, H. Liu

This paper demonstrates that non-T-cell based antigen depletion can induce apoptosis in CD19-expressing cancer cells, proposing a universal cellular therapy strategy using artificial antigen-recognizing cells.

bioRxiv · Mar 29, 2021Cancer Biology